<DOC>
	<DOCNO>NCT02080182</DOCNO>
	<brief_summary>In different study , show `` antioxidant '' utilization favorable therapeutic effect control acute symptom also prevention delay problem acute chronic pyelonephritis . According efficacy acetylcysteine potent antioxidant , safety drug side effect similar either less placebo , study design evaluate efficacy drug inflammatory biomarkers pediatric acute pyelonephritis . It triple-blind placebo control study population 64 patient 1-16 year old `` definite '' `` probable '' diagnosis acute pyelonephritis `` Mofid '' hospital . After randomization , patient give acetylcysteine placebo dose accord weight . Results treatment evaluate accord serum procalcitonin , C reactive protein leukocyte count drug prescription ( baseline ) 5 day drug prescription . Side effect also record group . Patients receive routine antimicrobial drug addition acetylcysteine .</brief_summary>
	<brief_title>Effect Acetylcysteine Pediatric Acute Pyelonephritis .</brief_title>
	<detailed_description />
	<mesh_term>Pyelonephritis</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Patients age 1 16 Having diagnosis `` definite '' `` probable '' urinary tract infection accord guideline `` pediatric infectious disease research center Patients young 1 old 16 year old Patients without diagnosis `` definite '' `` probable '' urinary tract infection accord guideline `` pediatric infectious disease research center '' Patients acute/ chronic infectious inflammatory disease pyelonephritis .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Acute Pyelonephritis</keyword>
	<keyword>Acetylcysteine</keyword>
	<keyword>Pediatric</keyword>
</DOC>